Cancer Network spoke with Tina Cascone, MD, of MD Anderson Cancer Center, at ASCO 2019 about combination checkpoint blockade in the pre-surgical setting for early-stage NSCLC.
Tina Cascone, MD, PhD
Advertisement
Articles by Tina Cascone, MD, PhD
Advertisement
Latest Updated Articles
Dr. Cascone on Combination Checkpoint Blockade for Early-Stage Non–Small-Cell Lung CancerPublished: June 7th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers
2
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
3
Bridging Radiotherapy Prior to CAR T May Be Safe in R/R Multiple Myeloma
4
Debate Round 3: Timing of Treatment Initiation in LR-MDS (Earlier vs Delayed)
5
